Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting

Condition:   2nd-line, 3rd-line and Greater Metastatic Pancreatic CancerInterventions:   Biological: GVAX Pancreas Vaccine;   Biological: CRS-207;   Drug: gemcitabine, capecitabine, 5-FU, irinotecan or erlotinib;   Drug: cyclophosphamideSponsor:   Aduro BioTech, Inc.Recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials